Northern Trust
ABEO icon

Northern Trust’s Abeona Therapeutics ABEO Stock Holding History

Northern Trust’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.95M Buy
435,973
+16,643
+4% +$83.2K ﹤0.01% 2988
2025
Q4 		$2.21M Sell
419,330
-2,897
-0.7% -$14.6K ﹤0.01% 2939
2025
Q3 		$2.23M Sell
422,227
-11,995
-3% -$76.1K ﹤0.01% 2977
2025
Q2 		$2.47M Buy
434,222
+253,402
+140% +$1.44M ﹤0.01% 2865
2025
Q1 		$861K Sell
180,820
-4,109
-2% -$22.3K ﹤0.01% 3344
2024
Q4 		$1.03M Buy
184,929
+11,478
+7% +$70.6K ﹤0.01% 3380
2024
Q3 		$1.1M Sell
173,451
-99
-0.1% -$517 ﹤0.01% 3325
2024
Q2 		$736K Buy
173,550
+44,849
+35% +$229K ﹤0.01% 3365
2024
Q1 		$933K Sell
128,701
-3,222
-2% -$20.4K ﹤0.01% 3337
2023
Q4 		$661K Buy
131,923
+23,276
+21% +$102K ﹤0.01% 3450
2023
Q3 		$457K Buy
108,647
+5,412
+5% +$20.5K ﹤0.01% 3546
2023
Q2 		$416K Buy
103,235
+69,539
+206% +$243K ﹤0.01% 3590
2023
Q1 		$95K Buy
+33,696
New +$88.1K ﹤0.01% 4093
2022
Q3 		– Sell
-7,334
Closed -$38K – 4710
2022
Q2 		$38K Hold
7,334
– – ﹤0.01% 4477
2022
Q1 		$58K Sell
7,334
-48
-0.7% -$330 ﹤0.01% 4500
2021
Q4 		$62K Sell
7,382
-1,425
-16% -$26.2K ﹤0.01% 4551
2021
Q3 		$246K Buy
8,807
+3,313
+60% +$106K ﹤0.01% 4084
2021
Q2 		$214K Sell
5,494
-19,593
-78% -$799K ﹤0.01% 4136
2021
Q1 		$1.18M Sell
25,087
-2,516
-9% -$139K ﹤0.01% 3515
2020
Q4 		$1.08M Sell
27,603
-167
-0.6% -$5.69K ﹤0.01% 3485
2020
Q3 		$708K Sell
27,770
-1,101
-4% -$69.4K ﹤0.01% 3518
2020
Q2 		$2.1M Buy
28,871
+3,399
+13% +$235K ﹤0.01% 3027
2020
Q1 		$1.34M Buy
25,472
+8,773
+53% +$586K ﹤0.01% 3067
2019
Q4 		$1.36M Buy
16,699
+719
+4% +$50.7K ﹤0.01% 3294
2019
Q3 		$903K Sell
15,980
-345
-2% -$25.8K ﹤0.01% 3419
2019
Q2 		$1.95M Buy
16,325
+313
+2% +$52.5K ﹤0.01% 3092
2019
Q1 		$2.95M Sell
16,012
-955
-6% -$171K ﹤0.01% 2853
2018
Q4 		$3.03M Sell
16,967
-232
-1% -$50.6K ﹤0.01% 2816
2018
Q3 		$5.5M Buy
17,199
+1,585
+10% +$562K ﹤0.01% 2629
2018
Q2 		$6.25M Buy
15,614
+3,437
+28% +$1.5M ﹤0.01% 2564
2018
Q1 		$4.37M Buy
12,177
+157
+1% +$58.3K ﹤0.01% 2669
2017
Q4 		$4.76M Buy
12,020
+1,725
+17% +$713K ﹤0.01% 2640
2017
Q3 		$4.39M Sell
10,295
-12
-0.1% -$3.23K ﹤0.01% 2707
2017
Q2 		$1.65M Buy
10,307
+8,271
+406% +$1.13M ﹤0.01% 3280
2017
Q1 		$254K Buy
2,036
+278
+16% +$35.9K ﹤0.01% 3722
2016
Q4 		$213K Buy
1,758
+791
+82% +$124K ﹤0.01% 3740
2016
Q3 		$145K Buy
967
+332
+52% +$32.5K ﹤0.01% 3809
2016
Q2 		$37K Sell
635
-3,563
-85% -$244K ﹤0.01% 4054
2016
Q1 		$268K Buy
4,198
+7
+0.2% +$464 ﹤0.01% 3631
2015
Q4 		$352K Sell
4,191
-14
-0.3% -$1.4K ﹤0.01% 3587
2015
Q3 		$426K Buy
4,205
+3,569
+561% +$474K ﹤0.01% 3534
2015
Q2 		$80K Buy
+636
New +$95.5K ﹤0.01% 3983

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust's ABEO Position: Q1 2026 in Review

Northern Trust increased its Abeona Therapeutics (ABEO) stake by 4% in Q1 2026, buying an estimated $83.2K and bringing the position to 435,973 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Northern Trust first reported a position in ABEO in Q2 2015 and has held it in 42 quarters since. The position peaked at $6.25M in Q2 2018. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Northern Trust held 435,973 shares of Abeona Therapeutics worth $1.95M as of Q1 2026.
  • Northern Trust bought 16,643 Abeona Therapeutics shares in Q1 2026, an estimated $83.2K.
  • Abeona Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2988 holding.
  • Northern Trust first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 42 quarters since.
  • Northern Trust's Abeona Therapeutics position peaked at $6.25M in Q2 2018.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.